CONTRIBUTION AND EXCHANGE AGREEMENTContribution and Exchange Agreement • June 4th, 2021 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 4th, 2021 Company Industry JurisdictionTHIS CONTRIBUTION AND EXCHANGE AGREEMENT (the “Agreement”) is made effective as of the 1st day of September, 2020 (the “Contribution Date”) by and among the undersigned Shareholders (the “Shareholders”) of record of Monte Rosa Therapeutics AG, a company incorporated in Switzerland, having its registered office at Aeschenvorstadt 36, 4051 Basel, Switzerland (“MRTx Swiss”) as of immediately prior to the Contribution and Exchange (as defined below), and MONTE ROSA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
CONTRIBUTION AND EXCHANGE AGREEMENTContribution and Exchange Agreement • June 4th, 2021 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 4th, 2021 Company Industry JurisdictionTHIS CONTRIBUTION AND EXCHANGE AGREEMENT (THE “AGREEMENT”) IS MADE EFFECTIVE AS OF THE 14th DAY OF APRIL, 2020 (THE “CONTRIBUTION DATE”) BY AND AMONG THE UNDERSIGNED SHAREHOLDERS (THE “SHAREHOLDERS”) OF RECORD OF MONTE ROSA THERAPEUTICS AG, A COMPANY INCORPORATED IN SWITZERLAND, HAVING ITS REGISTERED OFFICE AT AESCHENVORSTADT 36, 4051 BASEL, SWITZERLAND (“MRTX SWISS”) AS OF IMMEDIATELY PRIOR TO THE CONTRIBUTION AND EXCHANGE (AS DEFINED BELOW), AND MONTE ROSA THERAPEUTICS, INC., A DELAWARE CORPORATION (THE “COMPANY”).